New research led by Strollo and Patel found that the investigational oral therapy AD109 significantly reduced breathing interruptions and improved oxygen levels in adults with obstructive sleep apnea who could not tolerate CPAP.
Patrick Strollo, Jr., MD, and Sanjay Patel, MD, MS, Coauthor Phase 3 Trial of First Once-Nightly Pill for Sleep Apnea
Kristen